Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Monosialotetrahexosylganglioside for Cerebral Radiation Necrosis

NCT01884987 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT01884987
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01884987 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Monosialotetrahexosylganglioside for Cerebral Radiation Necrosis
Lead sponsor
Fudan University
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2012
Completion date
December 31, 2014
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral radiation necrosis, mri, nasopharyngeal carcinoma, radiotherapy